Unknown

Dataset Information

HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland.


ABSTRACT:

Background

HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross-resistance among representatives of this class of antiretrovirals. The aim of this study was to analyse integrase sequence variability among antiretroviral treatment naive and experienced patients with no prior integrase inhibitor (InI) exposure and investigate development of the InI drug resistance mutations following the virologic failure of the raltegravir containing regimen.

Methods

Sequencing of HIV-1 integrase region from plasma samples of 80 integrase treatment naive patients and serial samples from 12 patients with observed virologic failure on raltegravir containing treatment whenever plasma vireamia exceeded >50 copies/ml was performed. Drug resistance mutation

SUBMITTER: Parczewski M 

PROVIDER: S-EPMC3547692 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature